ISTHMUS PARTNERS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 169 filers reported holding HAEMONETICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ISTHMUS PARTNERS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2015$429,000
+8.3%
13,300
+8.6%
0.15%
+3.4%
Q3 2015$396,000
-19.8%
12,244
+2.6%
0.14%
-11.0%
Q2 2015$494,000
-2.8%
11,939
+5.6%
0.16%
-5.2%
Q1 2015$508,000
+25.1%
11,305
+4.1%
0.17%
+24.6%
Q4 2014$406,00010,8590.14%
Other shareholders
HAEMONETICS CORP shareholders Q1 2016
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders